06 — Test Roadmap
A future roadmap of diagnostic categories intended for clinics, community settings and decentralized care — each pending analytical, clinical and regulatory validation.
Roadmap · Future ValidationA roadmap of intended directions — not an approved test catalogue.
We're working toward a future menu of diagnostic categories for clinics, community settings and decentralized care. The scale reflects ambition, not current coverage.
Every category depends on analytical and clinical validation, reference comparison, cut-off determination, stability testing and regulatory review before it could be offered.
An exploratory signal-based blood analysis concept. Research only, pending analytical and clinical validation.
Clinical-chemistry and marker workflows in research, dependent on precision, interference and reference-comparison studies.
Public-health infection and microbiology research exploring future triage support, subject to validation.
A roadmap direction for respiratory and syndromic workflows. No approved infectious-disease claim implied.
Rapid-parameter workflows for critical-care settings, planned for exploration ahead of validation.
Community panel directions targeted for future validation and decentralized access after regulatory review.
Each area is a target for future validation, not an approved test. Availability is never implied — every direction sits behind the same analytical, clinical and regulatory gate.
A target for future validation — not an approved test.
A public-health research direction under exploration.
A roadmap direction requiring full validation first.
Planned clinical-chemistry panels; no availability implied.
Roadmap panels pending analytical and clinical validation.
A workflow roadmap, not a claim of certified interpretation.
A future-validation direction; no approved infectious-disease claim.
Community directions targeted for future validation.
A category advances only when the evidence supports it. Every direction must clear this sequence before it could be offered.
Precision, interference, stability, linearity and reference comparison.
Reference-method comparison and clinical performance testing.
Setting decision points before any use.
Regulatory strategy and approved labeling before any claim.
Tell us your organisation and how you'd like to collaborate.
Shared only with the BIQADX team · no spam.
